These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 30705687)

  • 1. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and clinical responses to Bunium Persicum (black caraway) supplementation in overweight and obese patients with type 2 diabetes: a double-blind, randomized placebo-controlled clinical trial.
    Jafari-Maskouni S; Shahraki M; Daneshi-Maskooni M; Dashipour A; Shamsi-Goushki A; Mortazavi Z
    Nutr Metab (Lond); 2020; 17():74. PubMed ID: 32863846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
    Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Nutr Metab (Lond); 2018; 15():63. PubMed ID: 30263038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
    Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Mohseni S; Safargar M; Mohtashamian A; Niknam S; Bakhoda M; Afshari S; Jafari A; Ebrahimzadeh A; Fooladshekan S; Mohtashami A; Ferns GA; Babajafari S; Sohrabi Z
    Complement Ther Med; 2024 Mar; 80():103025. PubMed ID: 38232906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial.
    Sohaei S; Amani R; Tarrahi MJ; Ghasemi-Tehrani H
    Complement Ther Med; 2019 Dec; 47():102201. PubMed ID: 31780025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial.
    Asghari KM; Saleh P; Salekzamani Y; Dolatkhah N; Aghamohammadzadeh N; Hashemian M
    Nutr Diabetes; 2024 Apr; 14(1):14. PubMed ID: 38589346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of neck circumference (NC) as a predictor of non-alcoholic fatty liver disease (NAFLD).
    Hu Y; Chen J; Yang L; Chen P; Li J; Chen L; Chen J; Huang X; Zhang Y; Bu S; Huang Q
    J Clin Transl Endocrinol; 2014 Dec; 1(4):133-139. PubMed ID: 29159094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
    Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M
    Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D supplementation improves SIRT1, Irisin, and glucose indices in overweight or obese type 2 diabetic patients: a double-blind randomized placebo-controlled clinical trial.
    Safarpour P; Daneshi-Maskooni M; Vafa M; Nourbakhsh M; Janani L; Maddah M; Amiri FS; Mohammadi F; Sadeghi H
    BMC Fam Pract; 2020 Feb; 21(1):26. PubMed ID: 32033527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial.
    Rezaei SMA; Mohammadi F; Eftekhari MH; Ejtehadi F; Ghaem H; Mohammadipoor N
    BMC Nutr; 2023 Nov; 9(1):138. PubMed ID: 38012749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of licorice extract in combination with a low-calorie diet on obesity indices, glycemic indices, and lipid profiles in overweight/obese women with polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial.
    Hooshmandi H; Ghadiri-Anari A; Ranjbar AM; Fallahzadeh H; Hosseinzadeh M; Nadjarzadeh A
    J Ovarian Res; 2024 Jul; 17(1):157. PubMed ID: 39080737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis.
    Molani-Gol R; Dehghani A; Rafraf M
    Phytother Res; 2024 Feb; 38(2):539-555. PubMed ID: 37918958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: a randomized controlled clinical trial.
    Arefhosseini S; Tutunchi H; Nomi-Golzar S; Mahboob S; Pouretedal Z; Ebrahimi-Mameghani M
    Food Funct; 2022 May; 13(9):5124-5134. PubMed ID: 35416190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.